CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis

Bisweswar Nandi(Brigham and Women's Hospital), Jason S. Gold(Memorial Sloan Kettering Cancer Center), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Christine Pai, Nikhil C. Munshi(Dana-Farber Cancer Institute), Rao Prabhala
PLoS ONE
May 27, 2014
10.1371/journal.pone.0097566
Cited by 52

Related Papers

Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
|The Lancet|2021|1.7k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
|Nature Communications|2014|906